These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25172968)

  • 1. Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease.
    Xu X; Ma H; Xu J; Huang H; Wu X; Xiong Y; Zhan H; Huang F
    Bosn J Basic Med Sci; 2014 Aug; 14(3):120-4. PubMed ID: 25172968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population.
    Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG
    Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum YKL-40 levels correlate with infarct volume, stroke severity, and functional outcome in acute ischemic stroke patients.
    Park HY; Jun CD; Jeon SJ; Choi SS; Kim HR; Choi DB; Kwak S; Lee HS; Cheong JS; So HS; Lee YJ; Park DS
    PLoS One; 2012; 7(12):e51722. PubMed ID: 23272150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma YKL-40 levels and ischemic stroke in the general population.
    Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG
    Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
    Jiang YX; Zhang GH; Wang ZM; Yang H
    Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis.
    Ural UM; Tekin YB; Cüre M; Şahin FK
    Clin Exp Obstet Gynecol; 2015; 42(4):495-7. PubMed ID: 26411218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke.
    Rathcke CN; Thomsen SB; Linneberg A; Vestergaard H
    PLoS One; 2012; 7(8):e43498. PubMed ID: 22937056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
    Ridker PM; Chasman DI; Rose L; Loscalzo J; Elias JA
    J Am Heart Assoc; 2014 Jun; 3(3):e000897. PubMed ID: 24958781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
    Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
    Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum YKL-40 level and dysglycemia in cystic fibrosis.
    Bouvet GF; Maignan M; Arslanian E; Coriati A; Rabasa-Lhoret R; Berthiaume Y
    Cytokine; 2015 Feb; 71(2):296-301. PubMed ID: 25497736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
    Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
    Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
    Wang X; Xing GH
    Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.
    Liu X; Zhang Y; Zhu Z; Ha M; Wang Y
    Med Oncol; 2014 Aug; 31(8):85. PubMed ID: 24996799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
    Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
    Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
    James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
    Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease.
    Kim HR; Jun CD; Lee KS; Cho JH; Jeong ET; Yang SH; Lee YJ; Park DS
    Cytokine; 2012 Jun; 58(3):336-43. PubMed ID: 22480951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.
    Bjørn ME; Andersen CL; Jensen MK; Hasselbalch HC
    Eur J Haematol; 2014 Sep; 93(3):224-8. PubMed ID: 24689875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population.
    Aguilera E; Serra-Planas E; Granada ML; Pellitero S; Reverter JL; Alonso N; Soldevila B; Mauricio D; Puig-Domingo M
    Cardiovasc Diabetol; 2015 Sep; 14():121. PubMed ID: 26382922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.